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Abstract 
In the last decade anti-cancer drugs, such as cisplatin, tamoxifen and 
cyclophosphamide, have seen their use greatly increase. Cisplatin is one of the most 
common anti-cancer drugs used in the EU which ubiquitous occurrence in surface 
waters, like rivers and estuaries, is related to the poor removal capacities of waste-water 
treatment plants (WWTPs). These drugs are genotoxic, cytotoxic, mutagenic and 
teratogenic. Therefore, this study includes a multibiomarker response analysis on 
mussel Mytilus galloprovincialis during two weeks of exposure to 100ng/l of cisplatin 
assessing antioxidant enzyme activity - catalase (CAT), glutathion-S-transferase (GST); 
lipid peroxidation (LPO) coupled with an enzyme assay to determine the inhibition 
effect of cisplatin, tamoxifen and cyclophosphamide (IC50) in the Ca
2+-ATPase. Results 
show that cisplatin does not seem to have an effect in the activity of CAT, GST and 
LPO and that its IC50 is 13.7 mM. The effect of the other two anti-cancer drugs were 
tamoxifen 0.271 mM and cyclophosphamide 1.134 μM. which makes Cisplatin much 
less dangerous than the other two anti-cancer drugs. 
Resumo 
Na última década, compostos anticancerígenos, como a cisplatina, tamoxifen e 
ciclofosfamida, tem tido um grande aumento de uso. A cisplatina é um dos 
anticancerígenos mais usados na UE cuja presença nas águas superficiais tal como rios e 
estuários resulta da falta de capacidade de remoção por parte das estações de tratamento 
de água (ETARs). Estes medicamentos tem capacidades genotóxica, citotóxicas, 
mutagénicas e teratogénica. O objetivo deste estudo é testar o efeito de vários 
biomarcadores em Mytilus galloprovincialis durante uma exposição de duas semanas a 
100ng/l de cisplatina e avaliar a atividade das enzimas antioxidantes- catálase (CAT), 
glutationa-S-transferase (GST); peroxidação lipídica (LPO) bem como determinar a 
concentração de inibição 50% (IC50) da cisplatina, tamoxifen e ciclofosfamida em Ca
2+-
ATPase. Os resultados mostram que a cisplatina não aparenta ter efeitos na atividade da 
CAT, GST e LPO e a sua IC50 é de 13.7 mM. Comparado os valores de IC50 com os de 
tamoxifen (0.271 mM) e ciclofosfamida (1.134 μM) indica que a cisplatina representa 
um risco muito inferior para Ca2+-ATPase do que os dois outros anticancerígenos.   
1. Introduction 
 
With the demographical increase of the world population the use and necessity of 
pharmaceutical drugs has greatly increased. And with this, the input of these drugs 
in the environment also has increased. Which has become one of the principal areas 
of interest in ecotoxicolocal investigation with the scope to understand the effect 
that the drugs have in the biodiversity and in the organisms. 
 
1.1. Anticancer drugs 
 
In the last decade the use of pharmaceuticals as increased and it’s detection in 
the environment has well. (Kosjek & Heath, 2011; Xie, 2012) Part of the 
pharmaceuticals consumed are excreted un-metabolized or are substances that 
can be reactivated in the sewage systems (Rowney, Johnson, & Williams, 2009). 
One of the import pharmaceuticals classes due to their genotoxicity, 
cytotoxicity, mutagenicity and teratogenicity that need to be much studied are 
the anticancer drugs (Kosjek & Heath, 2011).  
Anticancer drugs are classified as antineoplastic and immunomodulation agents 
(class L) and divided in alkylating agents (L01A), antimetabolites (L01B), 
natural products (L01C), cytotoxic antibiotics (L10D) and other antineoplasics 
(L01X) ( Kosjek and Heath 2011; Xie 2012; Booker et al. 2014).  
These drugs achieve the antitumor effect by causing direct DNA damage, 
inhibition of DNA synthesis, cell proliferation and induction of cell apoptosis 
( Rowney et al., 2009; Kosjek & Heath, 2011;  Xie, 2012; Booker et al., 2014; 
Turner & Mascorda, 2014; Vyas, Turner, & Sewell, 2014). Cytostatics act in a 
non-selective way in developing cells and may become carcinogen, until now it 
was not possible to say with certainty whether they have or not an 
environmental impact (Kosjek & Heath, 2011; Xie, 2012;  Vyas et al., 2014). 
Many of these substances are polar, soluble and non-volatile and have as 
principal source of liberation hospital and municipal effluents, due to the 
administration of the drugs to inpatients and outpatients  (Kosjek & Heath, 
2011; Booker et al., 2014). The wastewater-treatment plants do not have 
adequate equipment to remove totally these drugs which leads to their ongoing 
Figure 1: 
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molecular structure 
release in surface waters, rivers e estuaries ( Rowney et al., 2009; Booker et al., 
2014). 
 
To handle cytotoxic substances precaution measures are necessary. The drugs 
must be preserved in a dedicated and isolated local, the experiments must be 
done in a class II contaminant safety cabinet. And personal protection must be 
appropriate (Turner & Mascorda, 2014). 
 
Cyclophosphamide is classified as a classical alkylating agent. It is structurally 
similar to mustard gas, having a bis(2-chlorethyl) 
amine group capable of forming aziridinium. This 
group alkylates N7 of guanine bases and creates 
interstrand crosslinks in the DNA. This damage to 
the DNA blocks the transcription and replication of 
DNA, therefore being highly cytotoxic (Rowney et 
al., 2009; Xie, 2012). 
Cyclophosphamide is a polar compound with a small 
Kow (octanol-water partition coefficient), high 
solubility in water (solubility: 0.1-0.5 g/L), it is a substance with low 
biodegrability, the EC50 > 1000mg/L in various essays. The environmental 
concentration of cyclophosphamide reaches 10 μg/L in hospital effluents and 
0.2ng/L in surface waters ( Xie, 2012; Booker et al., 2014). 
 
Tamoxifen is classified as an endocrine 
disrupting drug that interfere with the 
endocrine system and disarray the 
reproduction system. It is a drug that 
contains 4-hydroxytamoxifen and N-
desmethyl4-hydroxytamoxifen. Both 
compounds are inhibitors of estrogen receptors 
which leads to the inhibition of the 
transcription of estrogen responsive genes (Xie, 2012). 
Figure 2: Tamoxifen molecular 
structure 
Tamoxifen is a lipophilic substance, with a high log Kow and low water 
solubility (solubility:17 mg/L), the EC50 > 5 μg/L in various essays. The 
environmental concentration of tamoxifen ranges from 0.2 to 8.2 ng/L in 
hospital effluents and <5.8ng/L in surface waters. Endocrine disruption caused 
by tamoxifen were only observed for concentration levels much higher than 
relevant environmental concentrations (Xie, 2012).  
 
1.1.1. Cisplatin 
 
Cisplatin is classified as a non-classical alkylating agent because it does not 
have the alkyl group like the mustard gas does. However it has a similar 
effect on DNA as the classic alkylating agent. 
 
In aqueous solutions that have few electrolytes the chloride ligands are 
replaced by water molecules: 
cis-PtCl2(NH3)2 + H2O ↔ cis-Pt(OH2)(𝑁𝐻3)2
+ + 𝐶𝑙− 
cis-Pt(OH2)(𝑁𝐻3)2
+ + 𝐶𝑙− ↔ cis-Pt(OH2)2(𝑁𝐻3)2
2+ + 𝐶𝑙− 
This reaction results in a aqueous species that is more reactive, known as 
monoaquacisplatin and diaquacisplatin, which binds to guanine base of the 
DNA and interfere with DNA replication and transcription (Bonnet et al. 
2003; Kosjek and Heath 2011; Xie 2012; Turner and Mascorda 2014; Vyas, 
Turner, and Sewell 2014) 
 
Cisplatin is a compound with a high 
polarity and a low Kow (Kow =-2.2), high 
solubility (solubility: 3*103 mg/L). The 
biodegradation of cisplatin is close to zero. 
DNA damage was noticed only with 
concentrations higher than 1mg/L (Kosjek 
and Heath 2011; Xie 2012; Turner and 
Figure 3: Cisplatin molecular 
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Mascorda 2014; Vyas, Turner, and Sewell 2014). Bonnet et al. (2003) 
determined the cisplatin EC50 of 37.31 ± 2.24mg/L for the ciliated 
protozoan tetraphymena pyriformis. 
 
1.1.1.1. Production, use and application 
 
Cancerostatic platinum compounds (CPCs) are one of the most used 
classes of antineoplastic in cancer therapy. Cisplatin is one of the three 
CPCs authorized in Europe. 
The production and use of CPCs in the last decade increased with the 
increase of cancer cases due to their efficiency in treatments. Usually the 
in and outpatients are administered a dose of 75-100 mg.m-2 body surface 
of cisplatin and 28±4% of the medication is excreted in the first 24h to 
hospital or urban effluents (Hann, Stefánka, Lenz, & Stingeder, 2005; 
Lenz et al., 2005). 
 
1.1.2. Environmental impact and toxicological effects 
 
Part of the cisplatin consumed by patients is eliminated from the human 
body unmetabolised or as conjugated substances that can be reactivated in 
urban effluents (Rowney et al., 2009). 
The concentration of cisplatin in hospital effluents range from 38 to 176 
ng/L. The constant release of cisplatin and other CPC’s to hospital effluents 
is problematic due to their capacity to interfere with DNA replication and 
transcription and so prevent cell development and even kill them (Xie, 
2012).  
IARC (1897) classified the cisplatin in group “2A- possibly cancerogenic 
to humans, an agent for which there is sufficient evidence of 
carcinogenicity in experimental animals” (in this case the assay were done 
in mouses).  
 
 
 
 
1.1.3. Aquatic organisms 
 
In the present any experiment exists with cisplatin in aquatic organisms. 
 
1.2. Biomarkers 
 
Biomarkers are quantitative measurements of changes at biochemical, 
molecular, cellular and physiological levels in organisms that may be related to 
effect and exposure to xenobiotic and environmental chemicals (Van der Oost, 
Porte-Visa, Van den Brink 2005; Gonzalez-Rey and Bebianno 2012; Vidal-
Liñán and Bellas 2013). 
 
In a situation of stress induced by pollutants it a sequence of biological reaction 
are triggered, which are used as a biomarker. Once a certain pollutant dose or 
exposure time is exceeded the pollutant-responsive biomarker signal deviate 
from the range of a normal situation (Van der Oost et al., 2005). 
The most important feature of biomarker research is the early identification of 
potential toxic effects relatively to time of exposure time and concentration 
(Van der Oost et al., 2005). Biomarker can be divided in three categories: ( Van 
der Oost, Beyer, & Vermeulen, 2003) 
 
I. Exposure biomarkers: that permit to measure and interaction with 
a target molecule or a xenobiotic substance; 
II. Effect biomarker: which measure biochemical, physiological or 
other alterations within tissues that can be associated to a possible 
disease or health damage; 
III. Susceptibility biomarker: indicates the capacity of an organism to 
respond and adapt to the exposure to certain xenobiotic. This 
includes genetic factors and changes in receptors that change the 
susceptibility to that xenobiotic. 
 
 
 
 
1.2.1. Phase II biotransformation enzymes 
 
Glutathion-S-transferase (GST) is classified as a phase II biotransformation 
enzyme which catalyse the process of conjugation of xenobiotics 
compounds or its metabolites with an endogenous ligand (Van der Oost et 
al., 2003) and so facilitate the excretion of chemicals by adding a more 
polar group like glutathione to the molecule (Van der Oost et al., 2005). A 
critical role of the GST is the defence against oxidative damage and 
peroxidative products of DNA (Van der Oost et al., 2003).  
 
1.2.2. Oxidative stress biomarkers 
 
Oxidative stress may be caused in organisms due to many environmental 
contaminants. When reactive oxygen species (ROS), or oxyradicals are  
present from exposure to cytotoxic compounds there occur oxygen toxicity 
(Van der Oost et al., 2003; Vlahogianni & Valavanidis, 2007) . The 
products of oxygen (O2) reduction are superoxide anion radical, hydrogen 
peroxide and hydroxyl radical, a potent oxidant capable of reacting with 
cellular molecules, leading to enzyme inhibition and lipid peroxidation 
(LPO) (Van der Oost et al., 2003). There are defence systems that inhibit 
oxyradicals formation being antioxidant enzymes such as catalase (CAT) 
one of them (Van der Oost et al., 2005). 
 
1.2.3. Biochemical indices of oxidative damage 
 
Many biochemical and physiological effects have been linked to increase 
of oxyradical production. One of the principal biochemical perturbations 
used as biomarker of oxidative damage is lipid peroxidation (LPO), or the 
oxidation of polyunsaturated fatty acids. Many studies demonstrated the 
increase of LPO in tissues of fish exposed to various chemicals ( Van der 
Oost et al., 2003; Vlahogianni & Valavanidis, 2007). 
 
 
1.3. Model system 
 
Bivalves, like mussels, have been used as sentinel organisms because they are 
sessile, filter feeders and wildly distributed. These organisms also have the 
capacity to accumulate contaminants from the water during their life ( Letendre 
et al. 2008; Gonzalez-Rey and Bebianno 2012; Marigómez et al. 2013; Jarque 
et al. 2014). 
Most of coastal monitoring programs use mussels from the intertidal zone, 
which are of easy access. It is necessary to take into account that the physiology 
of intertidal organisms is affected by the periods of submersion and emersion 
(Vidal-Liñán & Bellas, 2013). The closing of the shell during the emersion 
period and the loss of water through the paleal cavity imply a decrease of 
oxygen in the tissues. Because of this bivalves rapidly suffer from hypoxia or 
even anoxia when the emersion is prolonged (Letendre et al., 2008). 
Mytilus, is one of the genera most abundant of mussels and is usually used for 
research (Vlahogianni and Valavanidis 2007; Letendre et al. 2008; Gonzalez-
Rey and Bebianno 2011, 2012, 2013; Cappello et al. 2013; Marigómez et al. 
2013; Vidal-Liñán and Bellas 2013; Gonzalez-Rey et al. 2014; Jarque et al. 
2014). 
There are three taxas of Mytilus that inhabit European water. Two of these taxas 
are predominant: Mytilus edulis that lives in temperate and cold water from the 
European Atlantic coasts, and Mytilus galloprovincialis that inhabits warmer 
waters in the Mediterranean and extends to the north coast of France and the 
United Kingdom (Jarque et al., 2014). 
 
In the present study we analysed alterations of biomarkers such us catalase (CAT), 
gluthation-S.transferase (GST) activities and lipid peroxidation (LPO) in the gills and 
digestive gland of mussels, M. galloprovincialis, exposed to Cisplatin to try to 
understand if the release of this drug in the environment could have a significant 
impact in this species. Also the effects of cisplatin, cyclophosphamide and tamoxifen 
on Ca2+ATPase were assessed. Both studies aimed to evaluate the putative impact 
and the toxicity effects of anticancer drugs in the environment. 
  
2. Materials and methods 
 
2.1. Cisplatin 
Cisplatin was obtain from SIGMA P4394-250mg; CAS 15663-27-1 
 
2.1.1. Chemical Characterization  
1Chemical Formula Pt(NH3)2Cl2 
1Molecular weight 300.05 g.mol-1 
1Melting Point 270ºC 
1Form Yellow crystalline powder 
1Water Solubility 0.253g/100g 
2Log Kow -2.2 
1 Obtained from SIGMA CAS# 15663-27-1 
2 (Bonnet et al., 2003; Kosjek & Heath, 2011; Xie, 2012; Turner & Mascorda, 2014; Vyas et al., 
2014)  http://cisplatina.paginas.sapo.pt/ACisplatina.html; https://weweh.com 
 
A solution was prepared of 25ml with 57.69 mg of cisplatin diluted in water. For 
each contamination 1 ml of the solution was put in the tanks to obtain a 
concentration of 100 ng/l of cisplatin during the exposition. 
2.2. Model system and exposure 
 
2.2.1. Collection 
250 Mytilus galloprovincialis were collected from the Ria Formosa near Tavira 
(figure 4), in an area subjected to little human interaction.  
 
Figure 4: photos of the collection site 
2.2.2. Acclimatization 
The mussels were acclimatized for 7 days in two tanks with 25 litters of 
seawater. Temperature (18ºC ±1.5ºC) and salinity (36 ±1) were monitored and kept 
constant. The water was changed every two days. 
 
2.2.3. Exposure experiment 
The mussels were separated in groups of 
30 mussels per tank of 15 litters (2 
mussels/litter) (figure 5) in a triplicate design (3 
control tanks and 3 thanks contaminated with 
Cisplatin 100ng/l). The water was changed every 
two days and contamination re-established. The 
exposure lasted for 14 days and mussels were 
sampled in the beginning of the experiment and 
after 3, 7 and 14 days of exposure. 
 
2.3. Dissection 
 
 
10 mussels for each sampling time 
were dissected (Figure 6) and the gills, 
digestive gland and mantle frozen in liquid 
nitrogen and stored at -80ºC until the tissues 
were analysed. Shells were dried and weighted.    
 
 
 
 
Figure 5: photo of one of the tanks for 
the experiment 
Figure 6: open mussel 
  
2.4. Condition Index (CI) 
 
After weighing the tissues of the mussels and the shells, the condition index 
was calculated as the percentage of the ratio between the wet weight of the 
tissues and the total weight of the organisms (tissues plus shells). 
 
2.5. Total Proteins 
 
Total proteins were measured in the gills and digestive gland following the 
assay from Bradford (1976) which relies on the binding of the dye Coomassie 
Blue G-250 to proteins and the absorbance measured at 595nm. Measurements 
were made in a microplate reader using Bovine Serum albumin as a standard.  
Protein concentrations are expressed as mg.g-1 wet weight tissue. 
 
2.6. Oxidative Stress markers 
 
2.6.1. Catalase (CAT) 
 
CAT activity was measured from 100 μl of tissue by the decrease in 
absorbance at 240nm due to hydrogen peroxide (H2O2) consumption. The 
assay consisted in 1.95mL phosphate buffer, 1mL H2O2 and 0.05mL 
sample. The CAT activity is expressed in μmol.mg-1.total protein min-1. 
 
2.6.2. GST 
 
GST activity was determined in the cytosolic fraction by spectrometry at 
340nm based on the method of  Habig, Pabst, and Jakoby (1974). The GST 
activity is expressed in μmol.mg-1.total protein min-1. 
 
 
 
 
 2.7. Lipid Peroxidation 
 
The tissue samples were individually homogenised on ice with 20mM TRIS-
HCL buffer ant butylatedhydroxytoluene (BHT). Then it was centrifuged for 
45min at 30 000 x g for 45min to precipitate the cytosolic fraction. 
The lipid peroxidation was measured following the protocol of BIOXYTECH, 
LPO-586TM; Colorimetric Assay for Lipid Peroxidation by OxisResearchTM, 
a division of OXIS Health Products, Inc. In this case it was a combination of 
MDA with 4-hydroxyalkenals (in methanesulfonic acid). The LPO levels are 
expressed in MDA nmol.mg-1.total protein. 
 
2.8. Ca2+-ATPase 
 
Ca2+-ATPase activity in the presence of the several compounds was measured 
with spectrophotometry at 340 nm using coupled enzyme assay with pyruvate 
kinase and lactate desidrogenase following the experiment from Fraqueza et al 
(2013). Briefly, after the addition of the enzymes to the medium, NADP was 
added and then the vesicles from skeletal muscle sarcoplasmic reticulum 
containing the Ca –ATPase. Then, after the addition of ATP the values of the 
absorbance were recorded during about 1 minute and after that the ionophore 
was added and the decreased of the absorbance was measured during about 2 
minutes. The ATPase activity and the inhibition was measured taken into 
consideration the decrease of the OD (Optical density) per minute in the 
absence (100% ) and in the presence of the compounds cyclophosphamide, 
tamoxifen and cisplatin (Fraqueza, et al 2012). 
 
2.9. Statistical analysis 
Data were analysed using two-way ANOVA, one way ANOVA (non-
parametric ANOVA on ranks) and t-test to test differences between mussels 
form controls and exposed to cisplatin. The significance of the results was 
ascertained at p <0.05.  
3. Results 
 
3.1. Exposure Experiments  
 
3.1.1. Condition Index (CI) 
 
During the experiment the condition index was similar along the experiment. 
This imply that the physiological conditions of the organisms did not change 
during the experiment.  
 
Figure 7: Condition Index (CI) of mussels from control and exposed to Cisplatin. 
Different letters express significant differences (p<0.05) lower case letters indicate 
differences within the same treatment over time and uppercase letters indicate 
differences within the same time between treatments. 
 
3.2. Total Proteins 
 
Total proteins in the gills did not significantly change between mussels from 
control and exposed to cisplatin indicating that cisplatin has no influence in 
total protein content. However in the digestive gland total proteins 
concentrations decreased in the tissues exposed to cisplatin compared to the 
controls after 3 and 14 days of exposure. 
 Figure 8: Total proteins in the gills and digestive gland of mussels. Different letters 
express significant differences (p<0.05) lower case letters indicate differences within 
the same treatment over time and uppercase letters indicate differences within the same 
time between treatments. 
 
3.3. Oxidative Stress biomarkers 
 
3.3.1. CAT 
CAT activity did not change throughout all the exposure experiment in the gills 
and in the digestive gland in the controls and the exposed mussels except for the 
digestive gland after 14 days of exposure whose activity significantly increased 
as shown in figure 9-B. 
 
Figure 9: CAT activity in tissues exposed to Cisplatin. Different letters express 
significant differences (p<0.05) lower case letters indicate differences within the same 
treatment over time and uppercase letters indicate differences within the same time 
between treatments. 
 
3.3.2. GST 
 
The exposure of the mussels to cisplatin did not cause any change in the 
glutathione-S-transferase activity relatively to controls in the gills and digestive 
gland. However in the digestive gland like for CAT levels GST activity 
significantly increase by the end of the exposure period (fig 10-B). 
 
Figure 10: GST activity in tissues exposed to Cisplatin. Different letters express 
significant differences (p<0.05) lower case letters indicate differences within the same 
treatment over time and upper case letters indicate differences within the same time 
between treatments. 
 
3.4. Lipid Peroxidation 
 
In the gills, LPO has a transient variation in the gills of the mussels exposed to 
cisplatin compared to the controls which increased after 3 days of exposure and 
decreased gradually afterwards (fig 11-A). LPO in the digestive gland also 
increased after three days of exposure and decreased afterwards revealing a 
similar behaviour among tissues. 
